Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

A growth-hormone pill and ED: small studies, practical steps to consider

A recent discussion online links MK-677 to erectile dysfunction (ED), and people are asking whether the compound causes sexual problems. The headline makes it sound like a clear connection, but the available information is mostly scattered reports, small studies, or animal data. There is no big, definitive human trial that proves MK-677 causes ED across the board. MK-677 (also called ibutamoren) is not a steroid. It’s a drug that boosts levels of growth hormone by activating the ghrelin receptor — think of it like flipping a switch that tells your body to release more growth hormone and a related hormone called IGF-1. People use it experimentally for muscle and bone health, and sometimes for weight gain. It’s sold in some online markets but is not an approved medication for most uses, so quality and dosing can vary. What the research shows is mixed and limited. Some small studies in humans show MK-677 raises growth hormone and IGF-1 and can increase appetite and cause fluid retention. Reports of sexual side effects are mostly anecdotal (user reports on forums) or come from small case series, not large controlled trials. Animal studies give hints about hormone interactions, but animals don’t always predict human sexual function. A few studies have looked at hormones that affect libido and erections, but they don’t prove MK-677 directly causes ED. In short: there’s not enough high-quality human data to say MK-677 reliably produces erectile dysfunction. Why this matters is practical. Many people experimenting with performance or anti-aging compounds pay attention to sexual side effects because they’re particularly distressing. If you’re considering MK-677 for muscle, bone, or recovery reasons, the potential for appetite changes, fluid retention, sleepiness, and uncertain sexual effects is relevant. Also, because MK-677 can affect hormones, anyone with existing hormone-sensitive conditions (like prostate issues or certain cancers) should be cautious and talk to a doctor. The big caveats are important. MK-677 is often used outside medical supervision, so dosing and product purity vary. Known side effects include increased appetite, possible fluid retention, and transient increases in blood sugar and insulin resistance in some people. Long-term safety is unclear. People with diabetes or heart problems should be particularly careful. Because strong evidence linking MK-677 to ED is lacking, if you experience sexual side effects while taking it, stop and consult a healthcare professional to explore other causes and safer alternatives. Bottom line: MK-677 affects hormones and has some known side effects, but current human evidence does not definitively prove it causes erectile dysfunction; proceed cautiously and seek medical advice if you have symptoms.

Source: FC Bayern

Read full story

Back to Riding the pepTIDE